Medtronic stock holds near USD 93.80 after upgrade wave
Published on 09/15/2026 at 22:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medtronic plc stock (IE00BTN1Y115) traded at USD 93.80 on September 14, 2026, after a 3.1 percent rise, and the move came as analyst calls on September 15 kept piling up around the name.
Q1 fiscal 2027 sets the tone
On September 1, 2026, Medtronic reported first-quarter fiscal 2027 revenue of USD 9.76 billion and earnings per share of USD 1.45, both above estimates, while revenue rose 13.7 percent from the prior-year quarter and EPS improved from USD 1.26 a year earlier. MarketBeat said on September 15, 2026 that the stock had a consensus rating of Moderate Buy and an average target of USD 103.92.
The same report also said Medtronic set Q2 fiscal 2027 guidance at USD 1.320 to USD 1.340 EPS and full-year fiscal 2027 guidance at USD 5.940 to USD 6.000 EPS. For investors, that guidance band is now the cleaner benchmark than the one-day move.
Analysts stay constructive
The Globe and Mail reported on September 15, 2026 that Bank of America Securities kept a Buy rating and a USD 110 target, while the same piece said consensus stood at USD 103.41.
That sits close to MarketBeat's average target of USD 103.92 and above the last quoted price, which shows the market still prices in room for execution. A first.
Stock near the band
Medtronic stock changed hands at USD 93.80 on September 14, 2026, within GuruFocus' 52-week range of USD 73.31 to USD 106.33, after the shares gained 3.1 percent in that session. Market cap was listed at USD 120.07 billion in the MarketBeat update on September 15, 2026.
Medtronic stock at a glance
- Company: Medtronic plc
- ISIN: IE00BTN1Y115
- Ticker: MDT
- Trading venue: NYSE
- Price (as of September 14, 2026): USD 93.80
- Market capitalization: USD 120.07 billion (as of September 15, 2026)
- Sector / Industry: Health Care / Health Care Equipment
- Index membership: S&P 500
